ThePeptideGuide.uk LogoNavigation

Educational purposes only. Not medical advice. Consult healthcare professionals before use.

Healing & Recovery
Preclinical

Triptorelin

Triptorelin

Also known as: GnRH Agonist, Trelstar, Decapeptyl, Diphereline, Triptorelin Pamoate

Overview

Key Facts

Primary Goal: Research and therapeutic applications of Triptorelin

D-Trp6 substitution makes the peptide resistant to enzymatic cleavage, increasing potency ~100-fold over native GnRH. Acute administration causes a flare: robust release of LH and FSH from pituitary gonadotrophs.

Dosing Information

Half-Life

~3 hours (immediate release); depot formulations provide sustained release over weeks

Typical Dose

100–200 mcg

Frequency

single dose or as prescribed (depot formulations monthly/quarterly)

Cycle Length

Single dose in PCT protocols; months to years in clinical applications

Administration Routes:
subcutaneousintramuscular

Benefits

  • FDA-approved for prostate cancer, endometriosis, and precocious puberty
  • Single low-dose protocol researched for post-cycle testosterone recovery
  • Potent stimulation of LH/FSH during initial flare phase
  • Long-acting depot formulations available for clinical use

Side Effects

Initial testosterone/estrogen flare (first 1-2 weeks)mild
Hot flashesmild
Decreased libido during suppression phasemild
Injection site painmild
Bone mineral density loss with long-term suppressive usemild
Mood changes and emotional labilitymild

Mechanism of Action

1

D-Trp6 substitution makes the peptide resistant to enzymatic cleavage, increasing potency ~100-fold over native GnRH

2

Acute administration causes a flare: robust release of LH and FSH from pituitary gonadotrophs

3

Chronic continuous exposure downregulates and desensitizes GnRH receptors, suppressing LH, FSH, and downstream sex steroids

Contraindications

Do not use this peptide if any of the following apply:

  • Pregnancy (Category X)
  • Known hypersensitivity to GnRH or GnRH analogs
  • Undiagnosed vaginal bleeding
  • Osteoporosis or significant bone density loss

Storage & Reconstitution

Unreconstituted (Powder)

Temperature20–25°C (68–77°F) or -20°C (-4°F) for long-term
DurationUp to 3 months

Reconstituted (Mixed)

Temperature20–25°C (68–77°F)
Duration2-4 weeks

Research Summary

Preclinical

Triptorelin is FDA-approved under multiple brand names (Trelstar, Decapeptyl) for advanced prostate cancer, endometriosis, and central precocious puberty. In the peptide research community, it has gained interest due to a small 2009 study by Tan & Scally suggesting that a single low-dose (100 mcg) injection could significantly stimulate endogenous testosterone recovery after anabolic steroid-induced hypogonadism. While this application remains under-studied, the compound's clinical pharmacology is well-established.

Frequently Asked Questions

Common questions about Triptorelin

UK-Specific Information

Exclusive data points and guidance for UK residents using Triptorelin

UK Lab Testing

UK Lab Testing

Recommended labs: Medichecks, Thriva (£89-£149 for peptide safety panel)

Why this matters: UK-specific lab testing guidance not available on US competitor sites

Commonly Stacked With

Share on TikTok

Generate a trackable link to share this peptide information on TikTok